These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 26875830)

  • 1. Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease.
    DuPage M; Bluestone JA
    Nat Rev Immunol; 2016 Mar; 16(3):149-63. PubMed ID: 26875830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful.
    Kim HJ; Cantor H
    Cancer Immunol Res; 2014 Feb; 2(2):91-8. PubMed ID: 24778273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional plasticity in human FOXP3(+) regulatory T cells: implications for cell-based immunotherapy.
    d'Hennezel E; Piccirillo CA
    Hum Vaccin Immunother; 2012 Jul; 8(7):1001-5. PubMed ID: 22484225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of chemokines in adjusting the balance between CD4+ effector T cell subsets and FOXp3-negative regulatory T cells.
    Karin N; Wildbaum G
    Int Immunopharmacol; 2015 Oct; 28(2):829-35. PubMed ID: 25907241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimally invasive versus open Roux-en-Y gastric bypass: effect on immune effector cells.
    Whitson BA; D'Cunha J; Hoang CD; Wu B; Ikramuddin S; Buchwald H; Panoskaltsis-Mortari A; Kratzke RA; Miller JS; Maddaus MA
    Surg Obes Relat Dis; 2009; 5(2):181-93. PubMed ID: 18996756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T Helper Lymphocyte Subsets and Plasticity in Autoimmunity and Cancer: An Overview.
    Ivanova EA; Orekhov AN
    Biomed Res Int; 2015; 2015():327470. PubMed ID: 26583100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Perspectives for the immunotherapy of condylomata].
    Bourgault Villada I
    Ann Dermatol Venereol; 2000; 127(10 Suppl):3S23-3S25. PubMed ID: 11116860
    [No Abstract]   [Full Text] [Related]  

  • 8. T helper cells plasticity in inflammation.
    Cosmi L; Maggi L; Santarlasci V; Liotta F; Annunziato F
    Cytometry A; 2014 Jan; 85(1):36-42. PubMed ID: 24009159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic human CD4(+) T cells.
    van de Berg PJ; van Leeuwen EM; ten Berge IJ; van Lier R
    Curr Opin Immunol; 2008 Jun; 20(3):339-43. PubMed ID: 18440213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CD4+, CD25+ regulatory T-lymphocytes: current concepts and therapeutic potential].
    Salomon B
    J Soc Biol; 2002; 196(4):263-6. PubMed ID: 12645292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful immunotherapy induces previously unidentified allergen-specific CD4+ T-cell subsets.
    Ryan JF; Hovde R; Glanville J; Lyu SC; Ji X; Gupta S; Tibshirani RJ; Jay DC; Boyd SD; Chinthrajah RS; Davis MM; Galli SJ; Maecker HT; Nadeau KC
    Proc Natl Acad Sci U S A; 2016 Mar; 113(9):E1286-95. PubMed ID: 26811452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Melanoma-reactive CD4+ T-Cell Subsets From Human Melanoma Draining Lymph Nodes.
    Zhang M; Graor H; Yan L; Kim J
    J Immunother; 2016 Jan; 39(1):15-26. PubMed ID: 26641258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple roles for CD4+ T cells in anti-tumor immune responses.
    Kennedy R; Celis E
    Immunol Rev; 2008 Apr; 222():129-44. PubMed ID: 18363998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell subsets in immunologically-mediated glomerulonephritis.
    van Alderwegen IE; Bruijn JA; de Heer E
    Histol Histopathol; 1997 Jan; 12(1):241-50. PubMed ID: 9046059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decision making during the conception and career of CD4+ T cells.
    Reiner SL
    Nat Rev Immunol; 2009 Feb; 9(2):81-2. PubMed ID: 19172726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subsets of CD4 T cells and B cell activation.
    Bottomly K
    Semin Immunol; 1989 Sep; 1(1):21-31. PubMed ID: 15630956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of the lingual immune system reveals the presence of both regulatory and effector CD4+ T cells.
    Mascarell L; Lombardi V; Zimmer A; Louise A; Tourdot S; Van Overtvelt L; Moingeon P
    Clin Exp Allergy; 2009 Dec; 39(12):1910-9. PubMed ID: 19694757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human natural killer T cells are heterogeneous in their capacity to reprogram their effector functions.
    Eger KA; Sundrud MS; Motsinger AA; Tseng M; Van Kaer L; Unutmaz D
    PLoS One; 2006 Dec; 1(1):e50. PubMed ID: 17183680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A distinct role for ICOS-mediated co-stimulatory signaling in CD4+ and CD8+ T cell subsets.
    Watanabe M; Hara Y; Tanabe K; Toma H; Abe R
    Int Immunol; 2005 Mar; 17(3):269-78. PubMed ID: 15668466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous CD3 expression levels in differing T cell subsets correlate with the in vivo anti-CD3-mediated T cell modulation.
    Valle A; Barbagiovanni G; Jofra T; Stabilini A; Perol L; Baeyens A; Anand S; Cagnard N; Gagliani N; Piaggio E; Battaglia M
    J Immunol; 2015 Mar; 194(5):2117-27. PubMed ID: 25646305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.